Do analysts prefer NXGL or ZJYL?

NexGel currently has a consensus target price of $2.00, suggesting a potential upside of 348.93%. Given NexGel's stronger consensus rating and higher possible upside, equities analysts plainly believe NexGel is more favorable than Jin Medical International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NexGel 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings and valuation, NXGL or ZJYL?

Jin Medical International has higher revenue and earnings than NexGel. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio NexGel $11.42M 0.36 -$3M -$0.40 N/A Jin Medical International $20.69M 0.75 $1.19M N/A N/A

Which has higher valuation and earnings, NXGL or HIND?

NexGel has higher revenue and earnings than Vyome. NexGel is trading at a lower price-to-earnings ratio than Vyome, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio NexGel $11.42M 0.36 -$3M -$0.40 N/A Vyome $320K 48.04 -$10.26M -$12.27 N/A

Is NXGL or HIND more profitable?

Vyome has a net margin of 0.00% compared to NexGel's net margin of -28.54%. NexGel's return on equity of -64.29% beat Vyome's return on equity. Company Net Margins Return on Equity Return on Assets NexGel -28.54% -64.29% -29.64% Vyome N/A -203.92% -134.16%

Do analysts prefer NXGL or OSRH?

NexGel currently has a consensus price target of $2.00, suggesting a potential upside of 348.93%. Given NexGel's stronger consensus rating and higher probable upside, research analysts plainly believe NexGel is more favorable than OSR. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NexGel 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 OSR 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings & valuation, NXGL or OSRH?

NexGel has higher revenue and earnings than OSR. OSR is trading at a lower price-to-earnings ratio than NexGel, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio NexGel $11.42M 0.36 -$3M -$0.40 N/A OSR $2.91M 5.59 -$27.06M -$0.33 N/A

Is NXGL or OSRH more profitable?

NexGel has a net margin of -28.54% compared to OSR's net margin of -363.26%. OSR's return on equity of -7.24% beat NexGel's return on equity. Company Net Margins Return on Equity Return on Assets NexGel -28.54% -64.29% -29.64% OSR -363.26% -7.24% -5.41%

Is ICCM or NXGL more profitable?

NexGel has a net margin of -28.54% compared to IceCure Medical's net margin of -441.60%. NexGel's return on equity of -64.29% beat IceCure Medical's return on equity. Company Net Margins Return on Equity Return on Assets IceCure Medical -441.60% -211.73% -119.13% NexGel -28.54% -64.29% -29.64%

Which has higher valuation & earnings, FEMY or NXGL?

NexGel has higher revenue and earnings than Femasys. NexGel is trading at a lower price-to-earnings ratio than Femasys, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Femasys $2.29M 4.31 -$18.63M -$5.40 N/A NexGel $11.42M 0.36 -$3M -$0.40 N/A

Is FEMY or NXGL more profitable?

NexGel has a net margin of -28.54% compared to Femasys' net margin of -521.97%. NexGel's return on equity of -64.29% beat Femasys' return on equity. Company Net Margins Return on Equity Return on Assets Femasys -521.97% -258.08% -73.72% NexGel -28.54% -64.29% -29.64%

NexGel (NXGL) Competitors

$0.45 -0.03 (-5.49%)

Closing price 07/20/2026 04:00 PM Eastern

Extended Trading

$0.45 +0.00 (+0.11%)

As of 07/20/2026 04:10 PM Eastern

Compare

NXGL vs. ZJYL, HIND, OSRH, ICCM, and FEMY

Should you buy NexGel stock or one of its competitors? MarketBeat compares NexGel with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with NexGel include Jin Medical International (ZJYL), Vyome (HIND), OSR (OSRH), IceCure Medical (ICCM), and Femasys (FEMY). These companies are all part of the "medical equipment" industry.

How does NexGel compare to Jin Medical International?

NexGel (NASDAQ:NXGL) and Jin Medical International (NASDAQ:ZJYL) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and media sentiment.

Jin Medical International has higher revenue and earnings than NexGel.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NexGel	$11.42M	0.36	-$3M	-$0.40	N/A
Jin Medical International	$20.69M	0.75	$1.19M	N/A	N/A

2.2% of NexGel shares are held by institutional investors. 23.4% of NexGel shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Jin Medical International has a net margin of 0.00% compared to NexGel's net margin of -28.54%. Jin Medical International's return on equity of 0.00% beat NexGel's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NexGel	-28.54%	-64.29%	-29.64%
Jin Medical International	N/A	N/A	N/A

In the previous week, Jin Medical International had 1 more articles in the media than NexGel. MarketBeat recorded 1 mentions for Jin Medical International and 0 mentions for NexGel. NexGel's average media sentiment score of 0.00 equaled Jin Medical International'saverage media sentiment score.

Company	Overall Sentiment
NexGel	Neutral
Jin Medical International	Neutral

NexGel currently has a consensus target price of $2.00, suggesting a potential upside of 348.93%. Given NexGel's stronger consensus rating and higher possible upside, equities analysts plainly believe NexGel is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NexGel	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

NexGel has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.34, suggesting that its stock price is 634% more volatile than the broader market.

Summary

Jin Medical International beats NexGel on 8 of the 13 factors compared between the two stocks.

How does NexGel compare to Vyome?

NexGel (NASDAQ:NXGL) and Vyome (NASDAQ:HIND) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, analyst recommendations, institutional ownership, profitability, valuation and risk.

Vyome has a net margin of 0.00% compared to NexGel's net margin of -28.54%. NexGel's return on equity of -64.29% beat Vyome's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NexGel	-28.54%	-64.29%	-29.64%
Vyome	N/A	-203.92%	-134.16%

NexGel has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market. Comparatively, Vyome has a beta of 1.49, suggesting that its stock price is 49% more volatile than the broader market.

NexGel has higher revenue and earnings than Vyome. NexGel is trading at a lower price-to-earnings ratio than Vyome, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NexGel	$11.42M	0.36	-$3M	-$0.40	N/A
Vyome	$320K	48.04	-$10.26M	-$12.27	N/A

NexGel presently has a consensus price target of $2.00, suggesting a potential upside of 348.93%. Vyome has a consensus price target of $15.00, suggesting a potential upside of 584.93%. Given Vyome's stronger consensus rating and higher probable upside, analysts clearly believe Vyome is more favorable than NexGel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NexGel	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Vyome	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

In the previous week, Vyome had 1 more articles in the media than NexGel. MarketBeat recorded 1 mentions for Vyome and 0 mentions for NexGel. NexGel's average media sentiment score of 0.00 equaled Vyome'saverage media sentiment score.

Company	Overall Sentiment
NexGel	Neutral
Vyome	Neutral

2.2% of NexGel shares are held by institutional investors. Comparatively, 22.1% of Vyome shares are held by institutional investors. 23.4% of NexGel shares are held by company insiders. Comparatively, 33.0% of Vyome shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Vyome beats NexGel on 10 of the 15 factors compared between the two stocks.

How does NexGel compare to OSR?

NexGel (NASDAQ:NXGL) and OSR (NASDAQ:OSRH) are both small-cap medical equipment companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and profitability.

NexGel has a beta of 0.76, suggesting that its share price is 24% less volatile than the broader market. Comparatively, OSR has a beta of 0.72, suggesting that its share price is 28% less volatile than the broader market.

NexGel has a net margin of -28.54% compared to OSR's net margin of -363.26%. OSR's return on equity of -7.24% beat NexGel's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NexGel	-28.54%	-64.29%	-29.64%
OSR	-363.26%	-7.24%	-5.41%

NexGel currently has a consensus price target of $2.00, suggesting a potential upside of 348.93%. Given NexGel's stronger consensus rating and higher probable upside, research analysts plainly believe NexGel is more favorable than OSR.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NexGel	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
OSR	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

NexGel has higher revenue and earnings than OSR. OSR is trading at a lower price-to-earnings ratio than NexGel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NexGel	$11.42M	0.36	-$3M	-$0.40	N/A
OSR	$2.91M	5.59	-$27.06M	-$0.33	N/A

2.2% of NexGel shares are held by institutional investors. Comparatively, 55.3% of OSR shares are held by institutional investors. 23.4% of NexGel shares are held by company insiders. Comparatively, 36.9% of OSR shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, NexGel's average media sentiment score of 0.00 equaled OSR'saverage media sentiment score.

Company	Overall Sentiment
NexGel	Neutral
OSR	Neutral

Summary

NexGel beats OSR on 8 of the 14 factors compared between the two stocks.

How does NexGel compare to IceCure Medical?

IceCure Medical (NASDAQ:ICCM) and NexGel (NASDAQ:NXGL) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, media sentiment, dividends, valuation and profitability.

0.6% of IceCure Medical shares are held by institutional investors. Comparatively, 2.2% of NexGel shares are held by institutional investors. 2.4% of IceCure Medical shares are held by company insiders. Comparatively, 23.4% of NexGel shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

NexGel has higher revenue and earnings than IceCure Medical. NexGel is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IceCure Medical	$3.38M	3.38	-$15.06M	-$7.21	N/A
NexGel	$11.42M	0.36	-$3M	-$0.40	N/A

IceCure Medical presently has a consensus target price of $62.70, suggesting a potential upside of 1,782.88%. NexGel has a consensus target price of $2.00, suggesting a potential upside of 348.93%. Given IceCure Medical's stronger consensus rating and higher probable upside, analysts plainly believe IceCure Medical is more favorable than NexGel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IceCure Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
NexGel	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

NexGel has a net margin of -28.54% compared to IceCure Medical's net margin of -441.60%. NexGel's return on equity of -64.29% beat IceCure Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IceCure Medical	-441.60%	-211.73%	-119.13%
NexGel	-28.54%	-64.29%	-29.64%

IceCure Medical has a beta of 0.43, suggesting that its share price is 57% less volatile than the broader market. Comparatively, NexGel has a beta of 0.76, suggesting that its share price is 24% less volatile than the broader market.

In the previous week, IceCure Medical had 1 more articles in the media than NexGel. MarketBeat recorded 1 mentions for IceCure Medical and 0 mentions for NexGel. IceCure Medical's average media sentiment score of 0.00 equaled NexGel'saverage media sentiment score.

Company	Overall Sentiment
IceCure Medical	Neutral
NexGel	Neutral

Summary

NexGel beats IceCure Medical on 9 of the 15 factors compared between the two stocks.

How does NexGel compare to Femasys?

Femasys (NASDAQ:FEMY) and NexGel (NASDAQ:NXGL) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, risk, dividends, valuation, institutional ownership, profitability, earnings and analyst recommendations.

Femasys has a beta of -2.13, suggesting that its stock price is 313% less volatile than the broader market. Comparatively, NexGel has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market.

Femasys presently has a consensus price target of $106.67, indicating a potential upside of 3,161.98%. NexGel has a consensus price target of $2.00, indicating a potential upside of 348.93%. Given Femasys' stronger consensus rating and higher probable upside, equities analysts plainly believe Femasys is more favorable than NexGel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Femasys	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
NexGel	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Femasys' average media sentiment score of 0.00 equaled NexGel'saverage media sentiment score.

Company	Overall Sentiment
Femasys	Neutral
NexGel	Neutral

NexGel has higher revenue and earnings than Femasys. NexGel is trading at a lower price-to-earnings ratio than Femasys, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Femasys	$2.29M	4.31	-$18.63M	-$5.40	N/A
NexGel	$11.42M	0.36	-$3M	-$0.40	N/A

65.3% of Femasys shares are owned by institutional investors. Comparatively, 2.2% of NexGel shares are owned by institutional investors. 7.8% of Femasys shares are owned by company insiders. Comparatively, 23.4% of NexGel shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

NexGel has a net margin of -28.54% compared to Femasys' net margin of -521.97%. NexGel's return on equity of -64.29% beat Femasys' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Femasys	-521.97%	-258.08%	-73.72%
NexGel	-28.54%	-64.29%	-29.64%

Summary

NexGel beats Femasys on 8 of the 14 factors compared between the two stocks.

Get NexGel News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NXGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NXGL vs. The Competition

Export

Metric	NexGel	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$4.35M	$7.42B	$6.89B	$12.28B
Dividend Yield	N/A	1.32%	2.67%	9.39%
P/E Ratio	-1.11	49.51	27.07	23.94
Price / Sales	0.36	49.42	512.71	90.33
Price / Cash	N/A	26.91	26.68	47.25
Price / Book	0.74	6.96	10.63	6.14
Net Income	-$3M	$162.27M	$3.60B	$331.74M
7 Day Performance	-5.01%	-0.45%	-1.24%	-1.82%
1 Month Performance	-21.29%	-1.58%	1.09%	-1.45%
1 Year Performance	-81.36%	6.48%	23.66%	16.32%

NexGel Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NXGL NexGel	2.2641 of 5 stars	$0.45 -5.5%	$2.00 +348.9%	-81.6%	$4.35M	$11.42M	N/A	10
ZJYL Jin Medical International	0.6542 of 5 stars	$1.94 -1.0%	N/A	-85.0%	$15.34M	$20.69M	N/A	245	News Coverage Gap Up
HIND Vyome	2.7921 of 5 stars	$2.27 +4.1%	$15.00 +560.8%	N/A	$15.30M	$320K	N/A	50
OSRH OSR	0.5919 of 5 stars	$0.42 +16.1%	N/A	-56.3%	$12.71M	$2.91M	N/A	N/A	High Trading Volume
ICCM IceCure Medical	2.1704 of 5 stars	$3.60 flat	$62.70 +1,641.7%	-89.1%	$12.34M	$3.57M	N/A	60	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NXGL) was last updated on 7/21/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

NexGel (NXGL) Competitors

NXGL vs. ZJYL, HIND, OSRH, ICCM, and FEMY

How does NexGel compare to Jin Medical International?

Summary

How does NexGel compare to Vyome?

Summary

How does NexGel compare to OSR?

Summary

How does NexGel compare to IceCure Medical?

Summary

How does NexGel compare to Femasys?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NXGL vs. The Competition

NexGel Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

NexGel (NXGL) Competitors

NXGL vs. ZJYL, HIND, OSRH, ICCM, and FEMY

How does NexGel compare to Jin Medical International?

Which has better earnings and valuation, NXGL or ZJYL?

Do institutionals and insiders hold more shares of NXGL or ZJYL?

Is NXGL or ZJYL more profitable?

Does the media refer more to NXGL or ZJYL?

Do analysts prefer NXGL or ZJYL?

Which has more volatility & risk, NXGL or ZJYL?

Summary

How does NexGel compare to Vyome?

Is NXGL or HIND more profitable?

Which has more risk and volatility, NXGL or HIND?

Which has higher valuation and earnings, NXGL or HIND?

Do analysts rate NXGL or HIND?

Does the media prefer NXGL or HIND?

Do insiders and institutionals hold more shares of NXGL or HIND?

Summary

How does NexGel compare to OSR?

Which has more risk & volatility, NXGL or OSRH?

Is NXGL or OSRH more profitable?

Do analysts prefer NXGL or OSRH?

Which has higher earnings & valuation, NXGL or OSRH?

Do institutionals & insiders hold more shares of NXGL or OSRH?

Does the media refer more to NXGL or OSRH?

Summary

How does NexGel compare to IceCure Medical?

Do insiders and institutionals hold more shares of ICCM or NXGL?

Which has stronger earnings and valuation, ICCM or NXGL?

Do analysts recommend ICCM or NXGL?

Is ICCM or NXGL more profitable?

Which has more risk & volatility, ICCM or NXGL?

Does the media prefer ICCM or NXGL?

Summary

How does NexGel compare to Femasys?

Which has more risk and volatility, FEMY or NXGL?

Do analysts recommend FEMY or NXGL?

Does the media favor FEMY or NXGL?

Which has higher valuation & earnings, FEMY or NXGL?

Do insiders & institutionals believe in FEMY or NXGL?

Is FEMY or NXGL more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NXGL vs. The Competition

NexGel Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools